Skip to content

A Trial to Evaluate Inulin-Containing Food on Suppression of Postprandial Blood Glucose - Double Blind Randomized Placebo-Controlled Crossover Study -

A Trial to Evaluate Inulin-Containing Food on Suppression of Postprandial Blood Glucose - Double Blind Randomized Placebo-Controlled Crossover Study - - A Trial to Evaluate Inulin-Containing Food on Suppression of Postprandial Blood Glucose

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000039398
Enrollment
15
Registered
2020-02-05
Start date
2020-02-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Ingest the following three test foods in random order. Test food &quot
: inulin-containing food &quot
Carbohydrate load: retort cooked rice(300g) Intervals of each intervention are 5 days or more. Test food &quot
Carbohydrate load: retort cooked rice(300g) Placebo food: starch Carbohydrate load: retort cooked rice(300g)

Sponsors

Medical Corporation Hokubukai Utsukushigaoka Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Adult males from 20 to 64 years old at the time of giving consent. (2) Individuals whose fasting blood glucose values are from 110 to <126 mg/dL at the time of screening, or individuals whose postprandial blood glucose values at 120 min are from 140 to <200 mg/dL in 75 g OGTT at the screening. (3) Individuals who can make self-judgment to participate the study with their own will and can put signature and date to informed consent form by themselves prior to the study.

Exclusion criteria

Exclusion criteria: (1) Individuals who have serious medical history or have undergone resection surgery of digestive tract. (2) Individuals who have HbA1c (NGSP) values of 6.5 % or more. (3) Individuals continuously taking medication, FOSHU or health food product that may influence the results of this study. (4) Individuals who have allergies to Asteraceae plants and/or ingredients of the test foods or carbohydrate load. (5) Individuals with excessive alcohol drinking or heavy smoking. (6) Individuals judged as inappropriate for the study by the principal investigator.

Design outcomes

Primary

MeasureTime frame
The area under the curve (AUC) of blood glucose (measured and variation from baseline)

Secondary

MeasureTime frame
Blood glucose (measured), blood glucose Cmax (measured and variation from baseline), AUC of insulin (measured and variation from baseline), insulin (measured and variation from baseline), insulin Cmax (measured and variation from baseline)

Countries

Japan

Contacts

Public ContactTakuya Matsuda

Medical Corporation Hokubukai Utsukushigaoka Hospital Clinical Pharmacology Center

matsuda@ughp-cpc.jp011-882-0111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026